AP NEWS

Ra Pharmaceuticals to Present at Upcoming Investor Conferences

November 6, 2018

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 6, 2018--Ra Pharmaceuticals, Inc. (NASDAQ:RARX) today announced that senior management will present at the following upcoming investor conferences:

The Credit Suisse 27th Annual Healthcare Conference on Tuesday, November 13, 2018 at 4:35 p.m. M.T. The conference is being held at the Phoenician Resort in Scottsdale, AZ. The Stifel 2018 Healthcare Conference on November 13, 2018 at 3:30 p.m. E.T. The conference is being held at the Lotte New York Palace Hotel. The Jefferies Global Healthcare Conference on Thursday, November 15, 2018 at 2:40 p.m. GMT.

The presentations will be webcast live and can be accessed by visiting the investor relations section of the Company’s website, www.rapharma.com. A replay of the presentations will also be available and archived on the site for three weeks following each presentation.

About Ra Pharmaceuticals

Ra Pharmaceuticals is a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for complement-mediated diseases. The Company discovers and develops peptides and small molecules to target key components of the complement cascade. For more information, please visit: www.rapharma.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20181106005164/en/

CONTACT: Argot Partners

Investors:

Natalie Wildenradt

212-600-1902

natalie@argotpartners.com

or

Media:

David Rosen

212-600-1902

david.rosen@argotpartners.com

KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY CLINICAL TRIALS PHARMACEUTICAL

SOURCE: Ra Pharmaceuticals, Inc.

Copyright Business Wire 2018.

PUB: 11/06/2018 07:30 AM/DISC: 11/06/2018 07:30 AM

http://www.businesswire.com/news/home/20181106005164/en

AP RADIO
Update hourly